Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The 40-million-gallon-per-year precision fermentation plant will serve as a key production location for Nuol Green Chemistry’s advanced bio-based chemicals.
February 27, 2025
By: Charlie Sternberg
International Process Plants (IPP), a leader in repurposing industrial manufacturing sites, has leased its fermentation-based bio-acetone and bio-butanol plant in Little Falls, Minnesota, to Nuol Green Chemistry, a biochemical company focused on replacing petrochemical products with renewable and sustainable alternatives.
The 40-million-gallon-per-year precision fermentation plant will serve as a key production location for Nuol Green Chemistry’s advanced bio-based chemicals, including isobutanol and acetone. Strategically located in Minnesota’s bio-focused economy with access to major highways and a rail-adjacent site, the plant offers robust infrastructure for bio-based industrial production.
“This marks another significant milestone in IPP’s mission to drive the transition toward sustainable manufacturing using assets we have versus assets that need to be built new,” said Ronald Gale, President at IPP. “Nuol Green Chemistry’s leadership and technical teams bring many decades of proven expertise in renewable feedstock fermentation and biohydrolysis, aligning perfectly with our commitment to repurposing industrial assets such as this site for a greener future.”
The 27-acre property features commercial and pilot scale fermentation and distillation systems, utilities including wastewater, and comprehensive product testing laboratories. The plant’s capabilities include:
“Leasing this advanced facility from IPP enables us to accelerate the commercialization of our sustainable chemical products,” said Enrico Steagall, CEO at Nuol Green Chemistry. “With this plant, we will be able to supply high-value biochemicals that support decarbonization and reduce reliance on petrochemicals by using our novel technologies, including our unique enzymes.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !